Showing results (141-150 of 251) with videos related to

Sort By:
Pageof 26
Cephalalgia : an International Journal of Headache|December 2, 2023
Placebo and nocebo in the treatment of migraine: How much does real world effectiveness depend on contextual effects?Hauke Basedau, Raffaele Ornello, Eleonora De Matteis, et al.
Journal of the Neurological Sciences|February 22, 2023
New-onset headache following COVID-19: An Italian multicentre case seriesAngelo Torrente, Paolo Alonge, Vincenzo Di Stefano, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 26, 2026
Positron emission tomography for diagnosing cerebrovascular disorders: a scoping reviewFederica Nicoletta Sepe, Fabrizio Giammello, Giulia Fiume, et al.
The Journal of Headache and Pain|April 14, 2025
Differences in pharmacological migraine treatment across different levels of clinical headache care - a cross-sectional studyMira Pauline Fitzek, Lucas Hendrik Overeem, Marlene Ulrich, et al.
Headache|January 18, 2025
Pharmacological differences and switching among anti-CGRP monoclonal antibodies: A narrative reviewMarina Romozzi, Antonio Munafò, Andrea Burgalassi, et al.
Cephalalgia : an International Journal of Headache|August 19, 2020
Effect of calcitonin gene-related peptide (-receptor) antibodies in chronic cluster headache: Results from a retrospective case series support individual treatment attemptsRuth Ruscheweyh, Gregor Broessner, Gudrun Goßrau, et al.
The Journal of Headache and Pain|January 28, 2024
Health equity, care access and quality in headache - part 1Claudio Tana, Bianca Raffaelli, Marcio Nattan Portes Souza, et al.
The Journal of Headache and Pain|April 9, 2020
Real-life data on the efficacy and safety of erenumab in the Abruzzo region, central ItalyRaffaele Ornello, Alfonsina Casalena, Ilaria Frattale, et al.
Cephalalgia : an International Journal of Headache|November 5, 2024
Outcomes, unmet needs, and challenges in the management of patients who withdraw from anti-CGRP monoclonal antibodies: A prospective cohort studyAndrea Burgalassi, Marina Romozzi, Giulia Vigani, et al.
Pageof 26